Business
ALNOV: Acquisition delivers immediate profitability, expanded portfolio, and direct market access
ALNOV: Acquisition delivers immediate profitability, expanded portfolio, and direct market access
About this update from Novacyt Sas
Acquisition of Southern Cross Diagnostics accelerates growth, profitability, and product expansion, with immediate accretive impact and direct access to key customers in Australia and New Zealand. Capital raise was oversubscribed, strengthening the balance sheet and supporting future product launches and partnerships.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.